✦ LIBER ✦

Three-year survival in metastatic non-small cell lung cancer treated with gefitinib

✍ Scribed by Costa, Daniel B.; Schumer, Susan T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term survival in three patients wit

✍ Nakatomi, Katsumi; Soda, Hiroshi; Kitazaki, Takeshi; Nakano, Hirofumi; Uchida, K 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Predictive factors associated with prolo

✍ Satouchi, M; Negoro, S; Funada, Y; Urata, Y; Shimada, T; Yoshimura, S; Kotani, Y 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 123 KB

Gefitinib in advanced non-small cell lun

✍ R. Sharma; M. Boyer; S. Clarke; M. Millward 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB

Serum tumor markers as predictors for su

✍ Chiu, Chao-Hua; Shih, Yu-Ning; Tsai, Chun-Ming; Liou, Jia-Ling; Chen, Yuh-Min; P 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Predictive Factors for Interstitial Lung

✍ Ando, M. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 294 KB

Prognostic Factors for Gefitinib-Treated

✍ Okami, Jiro; Taniguchi, Kazuya; Higashiyama, Masahiko; Maeda, Jun; Oda, Kazuyuki 📂 Article 📅 2007 🏛 S. Karger AG 🌐 English ⚖ 228 KB